Naomi B. Haas, MD

faculty photo
Professor of Medicine (Hematology-Oncology) at the Hospital of the University of Pennsylvania
Director, Prostate and Kidney Cancer Program, University of Pennsylvania
Co-Leader of the Cancer Therapeutics Program, Abramson Cancer Center
Department: Medicine

Contact information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
10th Floor South Pavilion
Office #10-112
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: 215-662-7402
Fax: 215-349-8550
Education:
B.S. (Integrated Life Sciences)
Kent State University, 1985.
M.D.
Northeastern Ohio Universities College of Medicine, 1985.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

I am an international expert in the conduct and design of adjuvant clinical trials for kidney cancer
I am a national expert in prostate and kidney cancer therapeutics

Selected Publications

Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD: Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. Diabetes Care 37(7): 1910-7, Feb 2014 Notes: DOI: 10.2337/dc13-1489.

Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A: Phase II trial of Vorinostat in advanced melanoma. Invest New Drugs 32(3): 526-34, Jan 2014 Notes: ISSN 0167-6997.

Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL, Hussain M. : Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. J Clin Oncol 31(4): 412-9, Feb 2013.

Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R. : Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol 31(2): 181-6, Jan 2013 Notes: DOI: 10.1200/JCO.2012.43.3383.

Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N. : Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. Int J Radiat Oncol Biol Phys 83(5): 1493-9, Aug 2012 Notes: DOI: 10.1016/j.ijrobp.2011.10.047.

Haas Naomi B, Lin Xinyi, Manola Judith, Pins Michael, Liu Glenn, McDermott David, Nanus David, Heath Elisabeth, Wilding George, Dutcher Janice: A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Medical oncology (Northwood, London, England) 29(2): 761-7, Jun 2012.

Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N, Bekelman JE: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 83(1): 8-15, May 2012.

Swisher-McClure Samuel, Pollack Craig E, Christodouleas John P, Guzzo Thomas J, Haas Naomi B, Vapiwala Neha, Bekelman Justin E: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. International journal of radiation oncology, biology, physics 83(1): 8-15, May 2012.

Yeboa DN, Guzzo T, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K, Bekelman JE. : Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology Nov 2011.

Yeboa Debra Nana, Guzzo Thomas, Mitra Nandita, Christodouleas John P, Haas Naomi B, Vapiwala Neha, Armstrong Katrina, Bekelman Justin E: Prostate-specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology 78(5): 1107-13, Nov 2011.

back to top
Last updated: 11/12/2023
The Trustees of the University of Pennsylvania